Karen Noblett Axonics, Inc. (AXNX) insider trading activity

Karen Noblett is Chief Medical Officer of Axonics, Inc.. Currently has a direct ownership of 34,428 shares of AXNX, which is worth approximately $2.32 Million. The most recent transaction as insider was on Jan 31, 2024, when has been sold 11,288 shares (Common Stock) at a price of $67.74 per share, resulting in proceeds of $764,649. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.4K

0% 3M change

18.45% 12M change

Total Value Held $2.32 Million

Karen Noblett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2024	SELL Open market or private sale	$764,649 $67.74 p/Share	11,288 Reduced 24.69%	34,428 Common Stock
Jan 31 2024	BUY Exercise of conversion of derivative security	-	27,500 Added 37.56%	45,716 Common Stock
Jan 08 2024	SELL Open market or private sale	$1,103,931 $69.0 p/Share	15,999 Reduced 46.76%	18,216 Common Stock
Dec 28 2023	SELL Open market or private sale	$446,187 $63.28 p/Share	7,051 Reduced 17.09%	34,215 Common Stock
Dec 26 2023	SELL Open market or private sale	$59,787 $63.0 p/Share	949 Reduced 2.25%	41,266 Common Stock
Feb 01 2023	SELL Open market or private sale	$56,539 $60.73 p/Share	931 Reduced 2.16%	42,215 Common Stock
Jan 31 2023	SELL Open market or private sale	$226,401 $61.14 p/Share	3,703 Reduced 7.9%	43,146 Common Stock

Jan 31 2023	BUY Exercise of conversion of derivative security	-	10,250 Added 17.95%	46,849 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	5,000 Added 12.02%	36,599 Common Stock
Sep 12 2022	SELL Open market or private sale	$2,538,871 $78.16 p/Share	32,483 Reduced 50.69%	31,599 Common Stock
Sep 12 2022	BUY Exercise of conversion of derivative security	$649,985 $20.01 p/Share	32,483 Added 33.64%	64,082 Common Stock
Sep 07 2022	SELL Open market or private sale	$747,775 $71.53 p/Share	10,454 Reduced 24.86%	31,599 Common Stock
Mar 18 2022	SELL Open market or private sale	$774,379 $57.23 p/Share	13,531 Reduced 24.34%	42,053 Common Stock
Feb 03 2022	SELL Open market or private sale	$324,879 $48.62 p/Share	6,682 Reduced 10.73%	55,584 Common Stock
Feb 03 2022	BUY Exercise of conversion of derivative security	-	19,463 Added 23.81%	62,266 Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	-	5,350 Added 11.11%	42,803 Common Stock

Karen Noblett

Chief Medical Officer

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXNX shares.

Notify only if

Value

Insider Trading

Get notified when an Axonics, Inc. insider buys or sells AXNX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Axonics, Inc.

Track Activities on AXNX

Account